Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

We see Flutter's financial health as sound. Debt/adjusted EBITDA stood at 3.1 times in 2024. We see this as manageable, given that the company has no meaningful debt due until 2028, when $1.6 billion ...

Apollo’s Matt O’Mara on stagflation, private credit, and why AI, energy and infrastructure will need billions in capital.